3-烟酰氧基丙基对氯苯氧异丁酸酯（I. 612）耐受性及其对血脂谱、止血和凝血-纤溶平衡影响的初步研究 - Suppr | 超能文献

[Preliminary study of the tolerance of 3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate (I. 612) and on its effects on plasma lipid pattern, hemostasis and clotting-fibrinolysis balance].

作者信息

Buzzelli G, Doni A, Lippi G, Resina A

出版信息

Clin Ter. 1979 May 15;89(3):251-66.

Abstract

摘要

相似文献

1

[Preliminary study of the tolerance of 3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate (I. 612) and on its effects on plasma lipid pattern, hemostasis and clotting-fibrinolysis balance].3-烟酰氧基丙基对氯苯氧异丁酸酯（I. 612）耐受性及其对血脂谱、止血和凝血-纤溶平衡影响的初步研究

Clin Ter. 1979 May 15;89(3):251-66.

2

[Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].

Clin Ter. 1979 Apr 30;89(2):127-49.

3

Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.关于喂食胆固醇的家兔以及服用氯贝丁酯的动脉粥样硬化患者中，血清脂质组分与血液凝固、纤维蛋白溶解和血小板聚集关系的研究。

Farmaco Sci. 1973 Sep;28(9):713-21.

4

[Nicotinic acid and fibrinolysis in humans. I. Regional fibrinolysis (cerebral, of the upper extremity and of the lower extremity) caused by "arterial" administration of nicotinic acid].[烟酸与人体纤维蛋白溶解。I. 烟酸“动脉内”给药引起的局部纤维蛋白溶解（脑、上肢和下肢）]

Riv Crit Clin Med. 1967 Dec;67(6):465-83.

5

[Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].

Arch Farmacol Toxicol. 1979 Apr;5(1):29-42.

6

[Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].[烟酸与人体纤维蛋白溶解。II. 烟酸“静脉”和“动脉”给药引起的快速耐受性和动态纤维蛋白溶解再激活（全身和局部）]

Riv Crit Clin Med. 1967 Dec;67(6):484-507.

7

[Changes in the coagulation and anti-coagulation systems of the blood under the influence of nicotinic acid].[烟酸影响下血液凝血及抗凝系统的变化]

Klin Med (Mosk). 1966 Jan;44(1):48-50.

8

[Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].

Arch Farmacol Toxicol. 1978 Apr;4(1):25-7.

9

[Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate].[氯苯氧异丁酸镁与肌醇六烟酸酯组合的药代动力学]

Acta Med Austriaca. 1977;4(3):120-4.

10

[Treatment of various types of hyperlipoproteinaemia with a combination of Mg-chlorophenoxy-isobutyrate and mesoinositol-hexanicotinate (author's transl)].用氯苯氧异丁酸镁和肌醇六烟酸酯联合治疗各种类型的高脂蛋白血症（作者译）

Arzneimittelforschung. 1979;29(10):1621-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。